Mission Statement

To leverage our growing intellectual property portfolio into commercialization partnerships, strategic licensing arrangements, and Iasis Molecular Sciences branded products that will provide value added, life-quality improving solutions to at risk patients in the areas of health care acquired infections, wound infection, and subsequent inflammation-related tissue loss associated with burn trauma, periodontal disease, and abnormal healing.

Our Founders

Today IMS functions as a Washington state LLC, with Dr. David Vachon as CEO/Managing Partner and Dr. Dorne Yager, an expert in wound healing and wound biochemistry.